Public and private funding increased
In terms of finances, the IBRI’s endowment had increased to nearly $112 million at December 31, 2018, thanks to receipt of an additional $5 million from the Eli Lilly and Company Foundation. Learn more about the IBRI endowment by reviewing its fact sheet.
In addition, during 2018, the Indiana State Budget Committee reviewed the IBRI’s comprehensive plan and the $20 million appropriation from the State of Indiana may now be requested from the Indiana Economic Development Corporation (IEDC) as the underlying milestones are achieved.
Experienced fundraiser recruited
In terms of leadership, we successfully recruited Stephanie Grinage as vice president for advancement to the team. As the IBRI’s top development officer, she is our primary strategic partner responsible for cultivating and maintaining new and existing relationships with major donors, and she is overseeing and managing all aspects of the IBRI’s fundraising programs. Stephanie is a veteran of several successful campaigns, including two which raised more than $1 billion each.
Construction begins on our new home
In terms of facilities, we took a major step toward the construction of our new home on Dec. 12, 2018, with the groundbreaking ceremony for the Advanced Ressearch and Innovation Buidling in the 16 Tech Innovation District project on Indianapolis’ near west side.
Not only will the new building house our offices and laboratories, tripling the amount of space we have now, but its full 120,000 square feet will also be the headquarters for the Central Indiana Corporate Partnership (CICP), including its talent and industry initiatives, and the Indiana Center for Regenerative Medicine and Engineering.
We are very excited about the tenant collaboration that will exist when the building opens in mid-2020. The new building and the 16 Tech project are discussed more extensively in this report.
Thank you to our valued stakeholders
As we reflect on 2018, we are excited and optimistic about the momentum we have gained, and we anticipate significant further progress in 2019. I want to wholeheartedly thank our talented employees who are responsible for our progress and growth, which was also made possible by the support and guidance of our Scientific Advisory Board and the Board of Directors.
I also want to especially thank those who donated and contributed to the IBRI in 2018. We are grateful for your interest and commitment, which helps us improve human and animal health on a local and global scale.